E. I. Eger

1.4k total citations
50 papers, 990 citations indexed

About

E. I. Eger is a scholar working on Anesthesiology and Pain Medicine, Developmental Neuroscience and Physiology. According to data from OpenAlex, E. I. Eger has authored 50 papers receiving a total of 990 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Anesthesiology and Pain Medicine, 20 papers in Developmental Neuroscience and 9 papers in Physiology. Recurrent topics in E. I. Eger's work include Anesthesia and Sedative Agents (24 papers), Anesthesia and Neurotoxicity Research (20 papers) and Cardiac, Anesthesia and Surgical Outcomes (6 papers). E. I. Eger is often cited by papers focused on Anesthesia and Sedative Agents (24 papers), Anesthesia and Neurotoxicity Research (20 papers) and Cardiac, Anesthesia and Surgical Outcomes (6 papers). E. I. Eger collaborates with scholars based in United States, Austria and United Kingdom. E. I. Eger's co-authors include Eugene P. Steffey, James D. Berry, J. R. Gillespie, Donald D. Koblin, A. R. Forbes, Neal H. Cohen, Deshi Dong, Natalie Peterson, Henry L. Bennett and Robyn Dwyer and has published in prestigious journals such as Journal of Applied Physiology, Journal of Pharmacology and Experimental Therapeutics and Anesthesiology.

In The Last Decade

E. I. Eger

47 papers receiving 938 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. I. Eger United States 19 499 260 226 222 171 50 990
Thomas H. Cromwell United States 14 426 0.9× 182 0.7× 248 1.1× 185 0.8× 87 0.5× 17 744
Arthur L. Quasha United States 8 468 0.9× 305 1.2× 224 1.0× 148 0.7× 218 1.3× 11 855
Bernard Brandstater United States 9 558 1.1× 224 0.9× 116 0.5× 265 1.2× 217 1.3× 14 1.1k
E. Gepts Belgium 14 1.1k 2.2× 604 2.3× 329 1.5× 382 1.7× 115 0.7× 24 1.5k
R.A. MILLAR United Kingdom 20 246 0.5× 168 0.6× 287 1.3× 128 0.6× 99 0.6× 62 1.0k
Steven H. Bahlman United States 12 353 0.7× 151 0.6× 202 0.9× 159 0.7× 82 0.5× 14 619
Diederik Nieuwenhuijs Netherlands 16 560 1.1× 249 1.0× 220 1.0× 152 0.7× 115 0.7× 23 1.4k
Lawrence J. Saidman United States 2 410 0.8× 167 0.6× 75 0.3× 202 0.9× 178 1.0× 3 648
Takahiko Kamibayashi Japan 15 657 1.3× 442 1.7× 360 1.6× 249 1.1× 107 0.6× 77 1.3k
Werner Flacke United States 24 809 1.6× 550 2.1× 506 2.2× 171 0.8× 220 1.3× 77 1.8k

Countries citing papers authored by E. I. Eger

Since Specialization
Citations

This map shows the geographic impact of E. I. Eger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. I. Eger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. I. Eger more than expected).

Fields of papers citing papers by E. I. Eger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. I. Eger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. I. Eger. The network helps show where E. I. Eger may publish in the future.

Co-authorship network of co-authors of E. I. Eger

This figure shows the co-authorship network connecting the top 25 collaborators of E. I. Eger. A scholar is included among the top collaborators of E. I. Eger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. I. Eger. E. I. Eger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eger, E. I., et al.. (2010). Bidirectional modulation of isoflurane potency by intrathecal tetrodotoxin and veratridine in rats. British Journal of Pharmacology. 159(4). 872–878. 16 indexed citations
2.
Gupta, DK & E. I. Eger. (2008). Inhaled Anesthesia: The Original Closed-Loop Drug Administration Paradigm. Clinical Pharmacology & Therapeutics. 84(1). 15–18. 8 indexed citations
3.
Eger, E. I.. (2000). Hypotension and intravenous administration of d-tubocurarine.. PubMed. 19(3). 404–5.
4.
Litscher, Gerhard, et al.. (1998). Effects of acupuncture on the oxygenation of cerebral tissue. Neurological Research. 20(sup1). S28–S32. 37 indexed citations
6.
Griffiths, Robert I., P. Ionescu, Zheng Fang, Donald D. Koblin, & E. I. Eger. (1997). Enhanced choline acetyltransferase activity does not explain the action of inhaled convulsants. British Journal of Anaesthesia. 79(3). 389–391. 3 indexed citations
7.
Katz, Jeffrey A., et al.. (1994). Hepatic Necrosis Associated with Herpesvirus After Anesthesia with Desflurane and Nitrous Oxide. Anesthesia & Analgesia. 78(6). 1173???1176–1173???1176. 8 indexed citations
8.
Dwyer, Robyn, Henry L. Bennett, E. I. Eger, & Natalie Peterson. (1992). Isoflurane Anesthesia Prevents Unconscious Learning. Anesthesia & Analgesia. 75(1). 107???112–107???112. 50 indexed citations
9.
Eger, E. I.. (1992). Desflurane animal and human pharmacology: aspects of kinetics, safety, and MAC.. PubMed. 75(4 Suppl). S3–7; discussion S8. 60 indexed citations
10.
Jones, R. Morley, et al.. (1990). BIOTRANSFORMATION AND HEPATO—RENAL FUNCTION IN VOLUNTEERS AFTER EXPOSURE TO DESFLURANE (1–653). British Journal of Anaesthesia. 64(4). 482–487. 34 indexed citations
11.
Eger, E. I.. (1990). Anesthetic Potency and Lipid Solubility. Anesthesia & Analgesia. 70(1). 118???119–118???119. 1 indexed citations
12.
Fassoulaki, Argyro, Kenneth Drasner, & E. I. Eger. (1990). Is Chronic Ethanol Consumption Associated With Tolerance to Intrathecal Lidocaine in the Rat?. Anesthesia & Analgesia. 70(5). 489???492–489???492. 6 indexed citations
13.
Jones, Rhys, et al.. (1989). Kinetics and potency of 1–653 in volunteers. Anesthesiology. 71(Supplement). A270–A270. 2 indexed citations
14.
Eger, E. I.. (1984). The pharmacology of isoflurane.. PubMed. 56 Suppl 1. 71S–99S. 158 indexed citations
15.
Koblin, Donald D., Deshi Dong, & E. I. Eger. (1979). Tolerance of mice to nitrous oxide.. Journal of Pharmacology and Experimental Therapeutics. 211(2). 317–325. 51 indexed citations
16.
Steffey, Eugene P., J. R. Gillespie, James D. Berry, E. I. Eger, & E. A. Rhode. (1975). Circulatory Effects of Halothane and Halothane-Nitrous Oxide Anesthesia in the Dog: Spontaneous Ventilation. American Journal of Veterinary Research. 36(2). 197–200. 9 indexed citations
17.
Steffey, Eugene P., J. R. Gillespie, James D. Berry, E. I. Eger, & E. A. Rhode. (1974). Cardiovascular Effects of Halothane in the Stump-Tailed Macaque During Spontaneous and Controlled Ventilation. American Journal of Veterinary Research. 35(10). 1315–1319. 4 indexed citations
18.
Steffey, EP, J. R. Gillespie, James D. Berry, E. I. Eger, & Edwin S. Munson. (1974). Anesthetic potency (MAC) of nitrous oxide in the dog, cat, and stump-tail monkey. Journal of Applied Physiology. 36(5). 530–532. 48 indexed citations
19.
Bahlman, Steven H., et al.. (1972). The Cardiovascular Effects of Halothane in Man during Spontaneous Ventilation. Anesthesiology. 36(5). 494–502. 34 indexed citations
20.
Bahlman, Steven H., et al.. (1971). The Cardiovascular Effects of Nitrous Oxide-Halothane Anesthesia in Man. Anesthesiology. 35(3). 274–284. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026